Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.34
(1.86%)
EUR 45.34
(1.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.55 Billion EUR | -14.58% |
| 2022 | 4.01 Billion EUR | 20.98% |
| 2021 | 3.31 Billion EUR | -1.25% |
| 2020 | 3.35 Billion EUR | 4.03% |
| 2019 | 3.22 Billion EUR | 7.67% |
| 2018 | 2.99 Billion EUR | -19.14% |
| 2017 | 3.7 Billion EUR | 21.63% |
| 2016 | 3.04 Billion EUR | 9.85% |
| 2015 | 2.77 Billion EUR | 22.0% |
| 2014 | 2.27 Billion EUR | 24.8% |
| 2013 | 1.82 Billion EUR | -1.03% |
| 2012 | 1.84 Billion EUR | -2.38% |
| 2011 | 1.88 Billion EUR | 13.0% |
| 2010 | 1.66 Billion EUR | 15.25% |
| 2009 | 1.44 Billion EUR | 3.1% |
| 2008 | 1.4 Billion EUR | 15.39% |
| 2007 | 1.21 Billion EUR | 3.07% |
| 2006 | 1.18 Billion EUR | 0.41% |
| 2005 | 1.17 Billion EUR | 29.32% |
| 2004 | 909.95 Million EUR | 6.96% |
| 2003 | 850.77 Million EUR | -7.11% |
| 2002 | 915.85 Million EUR | -35.32% |
| 2001 | 1.41 Billion EUR | 57.21% |
| 2000 | 900.69 Million EUR | -20.49% |
| 1999 | 1.13 Billion EUR | 21.86% |
| 1998 | 929.56 Million EUR | 0.0% |
| 1997 | - EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 698.73 Million EUR | -23.3% |
| 2024 Q3 | 796 Million EUR | -16.02% |
| 2024 Q2 | 813.79 Million EUR | 16.47% |
| 2023 Q4 | 911 Million EUR | -1.77% |
| 2023 Q2 | 840.17 Million EUR | -7.32% |
| 2023 Q3 | 927.4 Million EUR | 10.38% |
| 2023 Q1 | 906.54 Million EUR | -10.86% |
| 2023 FY | 3.42 Billion EUR | -14.58% |
| 2022 Q1 | 920.91 Million EUR | 3.36% |
| 2022 FY | 4.01 Billion EUR | 20.98% |
| 2022 Q2 | 1.02 Billion EUR | 11.29% |
| 2022 Q4 | 1.01 Billion EUR | -3.24% |
| 2022 Q3 | 1.05 Billion EUR | 2.55% |
| 2021 Q1 | 760.16 Million EUR | -20.57% |
| 2021 Q2 | 882.19 Million EUR | 16.05% |
| 2021 Q3 | 783.59 Million EUR | -11.18% |
| 2021 Q4 | 891 Million EUR | 13.71% |
| 2021 FY | 3.31 Billion EUR | -1.25% |
| 2020 Q4 | 957 Million EUR | 25.48% |
| 2020 Q1 | 900.37 Million EUR | 4.21% |
| 2020 Q2 | 789 Million EUR | -12.37% |
| 2020 Q3 | 762.67 Million EUR | -3.34% |
| 2020 FY | 3.35 Billion EUR | 4.03% |
| 2019 Q2 | 843.54 Million EUR | 12.66% |
| 2019 Q4 | 864 Million EUR | 11.68% |
| 2019 Q3 | 773.6 Million EUR | -8.29% |
| 2019 FY | 3.22 Billion EUR | 7.67% |
| 2019 Q1 | 748.77 Million EUR | -2.38% |
| 2018 Q3 | 768.42 Million EUR | 2.07% |
| 2018 Q2 | 752.82 Million EUR | 3.98% |
| 2018 Q1 | 724 Million EUR | -26.87% |
| 2018 Q4 | 767 Million EUR | -0.18% |
| 2018 FY | 2.99 Billion EUR | -19.14% |
| 2017 Q3 | 828.92 Million EUR | -11.31% |
| 2017 FY | 3.7 Billion EUR | 21.63% |
| 2017 Q4 | 990 Million EUR | 19.43% |
| 2017 Q2 | 934.64 Million EUR | -2.16% |
| 2017 Q1 | 955.26 Million EUR | 24.03% |
| 2016 Q1 | 702.29 Million EUR | -5.79% |
| 2016 Q4 | 770.18 Million EUR | 4.01% |
| 2016 Q3 | 740.49 Million EUR | 6.84% |
| 2016 Q2 | 693.05 Million EUR | -1.32% |
| 2016 FY | 3.04 Billion EUR | 9.85% |
| 2015 Q3 | 690.78 Million EUR | 2.34% |
| 2015 FY | 2.77 Billion EUR | 22.0% |
| 2015 Q2 | 675.01 Million EUR | 6.58% |
| 2015 Q1 | 633.33 Million EUR | 2.01% |
| 2015 Q4 | 745.44 Million EUR | 7.91% |
| 2014 Q1 | 472.44 Million EUR | 7.28% |
| 2014 Q4 | 620.88 Million EUR | 12.45% |
| 2014 FY | 2.27 Billion EUR | 24.8% |
| 2014 Q2 | 484.75 Million EUR | 2.61% |
| 2014 Q3 | 552.15 Million EUR | 13.91% |
| 2013 Q2 | 481.38 Million EUR | -0.9% |
| 2013 Q1 | 485.77 Million EUR | -6.55% |
| 2013 FY | 1.82 Billion EUR | -1.03% |
| 2013 Q4 | 440.36 Million EUR | -3.81% |
| 2013 Q3 | 457.8 Million EUR | -4.9% |
| 2012 Q4 | 519.83 Million EUR | 22.53% |
| 2012 FY | 1.84 Billion EUR | -2.38% |
| 2012 Q1 | 435.8 Million EUR | -21.13% |
| 2012 Q2 | 447.51 Million EUR | 2.69% |
| 2012 Q3 | 424.23 Million EUR | -5.2% |
| 2011 FY | 1.88 Billion EUR | 13.0% |
| 2011 Q4 | 552.58 Million EUR | 19.88% |
| 2011 Q3 | 460.94 Million EUR | 7.41% |
| 2011 Q2 | 429.13 Million EUR | 1.39% |
| 2011 Q1 | 423.25 Million EUR | -8.5% |
| 2010 Q3 | 411.81 Million EUR | -8.25% |
| 2010 Q1 | 402.83 Million EUR | -3.92% |
| 2010 Q2 | 448.85 Million EUR | 11.42% |
| 2010 FY | 1.66 Billion EUR | 15.25% |
| 2010 Q4 | 462.55 Million EUR | 12.32% |
| 2009 Q2 | 366.41 Million EUR | 4.21% |
| 2009 Q3 | 360 Million EUR | -1.75% |
| 2009 Q4 | 419.28 Million EUR | 16.47% |
| 2009 FY | 1.44 Billion EUR | 3.1% |
| 2009 Q1 | 351.59 Million EUR | -6.96% |
| 2008 Q2 | 314.44 Million EUR | 6.42% |
| 2008 FY | 1.4 Billion EUR | 15.39% |
| 2008 Q4 | 377.88 Million EUR | 9.36% |
| 2008 Q3 | 345.54 Million EUR | 9.89% |
| 2008 Q1 | 295.46 Million EUR | -2.1% |
| 2007 Q3 | 309.2 Million EUR | -6.23% |
| 2007 Q2 | 329.74 Million EUR | 4.97% |
| 2007 FY | 1.21 Billion EUR | 3.07% |
| 2007 Q1 | 314.14 Million EUR | -1.77% |
| 2007 Q4 | 301.81 Million EUR | -2.39% |
| 2006 Q2 | 279.6 Million EUR | 1.33% |
| 2006 Q4 | 319.79 Million EUR | 0.97% |
| 2006 FY | 1.18 Billion EUR | 0.41% |
| 2006 Q3 | 316.72 Million EUR | 13.28% |
| 2006 Q1 | 275.92 Million EUR | -15.37% |
| 2005 FY | 1.17 Billion EUR | 29.32% |
| 2005 Q4 | 326.03 Million EUR | 10.31% |
| 2005 Q3 | 295.56 Million EUR | 2.56% |
| 2005 Q2 | 288.18 Million EUR | 17.11% |
| 2005 Q1 | 246.07 Million EUR | 31.76% |
| 2004 FY | 909.95 Million EUR | 6.96% |
| 2004 Q4 | 186.76 Million EUR | -23.37% |
| 2004 Q2 | 256.17 Million EUR | 11.22% |
| 2004 Q3 | 243.71 Million EUR | -4.86% |
| 2004 Q1 | 230.32 Million EUR | 22.96% |
| 2003 Q2 | 225.01 Million EUR | -0.91% |
| 2003 Q1 | 227.08 Million EUR | 6.3% |
| 2003 FY | 850.77 Million EUR | -7.11% |
| 2003 Q4 | 187.32 Million EUR | -18.02% |
| 2003 Q3 | 228.5 Million EUR | 1.55% |
| 2002 Q2 | 238.58 Million EUR | 2.22% |
| 2002 Q3 | 256.2 Million EUR | 7.39% |
| 2002 Q4 | 213.62 Million EUR | -16.62% |
| 2002 FY | 915.85 Million EUR | -35.32% |
| 2002 Q1 | 233.39 Million EUR | -62.0% |
| 2001 FY | 1.41 Billion EUR | 57.21% |
| 2001 Q4 | 614.16 Million EUR | 120.68% |
| 2001 Q3 | 278.31 Million EUR | -3.25% |
| 2001 Q2 | 287.65 Million EUR | 8.4% |
| 2001 Q1 | 265.37 Million EUR | 584.51% |
| 2000 FY | 900.69 Million EUR | -20.49% |
| 2000 Q4 | -54.77 Million EUR | -111.34% |
| 2000 Q3 | 482.83 Million EUR | 119.4% |
| 2000 Q2 | 220.06 Million EUR | -24.31% |
| 2000 Q1 | 290.73 Million EUR | 108.92% |
| 1999 Q1 | - EUR | 100.0% |
| 1999 Q2 | - EUR | 0.0% |
| 1999 Q3 | - EUR | 0.0% |
| 1999 Q4 | -3.25 Billion EUR | 0.0% |
| 1999 FY | 1.13 Billion EUR | 21.86% |
| 1998 Q3 | - EUR | 0.0% |
| 1998 FY | 929.56 Million EUR | 0.0% |
| 1998 Q1 | - EUR | 0.0% |
| 1998 Q4 | -2.57 Billion EUR | 0.0% |
| 1998 Q2 | - EUR | 0.0% |
| 1997 Q4 | - EUR | 0.0% |
| 1997 Q2 | - EUR | 0.0% |
| 1997 FY | - EUR | 0.0% |
| 1997 Q1 | - EUR | 0.0% |
| 1997 Q3 | - EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 3.91 Billion EUR | 9.181% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -31630.034% |
| M1 Kliniken AG | 16.77 Million EUR | -21097.523% |
| Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | -20238.445% |
| MEDICLIN Aktiengesellschaft | 70.03 Million EUR | -4976.879% |
| RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | -2088.364% |
| VITA 34 AG | 31.36 Million EUR | -11236.459% |